Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities
Acta Neuropathologica · 09.05.2025 · 149 (1)
DOI: 10.1007/s00401-025-02883-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 09.05.2025. Verfasst von Fu Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Neurosurgery, Beijing Key Laboratory of Drug Innovation for Neuro-Oncology, Beijing Neurosurgical Institute, Capital Medical …. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neurilemmoma, Neurofibromatoses, Neurofibromatosis 2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Science and Technology Support Program of the 12th Five-Year Plan of China, Beijing Platform Construction of Basic Research and Clinical Translation of Nervous System Injury (2020), Beijing Natural Science Foundation.
Abstract (Originalsprache)
NF2-related schwannomatosis (NF2-SWN) is a genetic predisposition syndrome characterized by the development of bilateral vestibular schwannomas (VSs). Despite their benign nature and consistent histopathological characteristics, these tumours display significant clinical and therapeutic heterogeneity. To elucidate the molecular heterogeneity within NF2-SWN schwannomas, we performed comprehensive molecular analyses on a cohort of 70 patients with NF2-SWN, including bulk RNA sequencing, whole genome or exome sequencing, single nuclear RNA (snRNA) sequencing and immunohistochemistry. Our analysis identified two distinct molecular subgroups: immune-enriched schwannomas (IESs) and immune-depleted schwannomas (IDSs). IESs were commonly diagnosed in adulthood, followed a favorable prognosis, and were characterized by abundant macrophage infiltration within the tumour microenvironment. In contrast, IDSs were predominantly composed of Schwann cells, harbored germline NF2 mutations, occurred primarily during childhood and had poorer outcomes. Immunohistochemical staining for ionized calcium-binding adaptor molecule 1 (Iba1) and CD68, CD163 antibodies effectively differentiated these two subgroups of NF2-SWN schwannomas. Furthermore, we demonstrated that blockade of the colony stimulating factor 1 receptor (CSF1R) resulted in macrophage depletion and significantly suppressed tumour growth in both in vitro and in vivo models of IESs. Collectively, our study reveals two discrete molecular subgroups within NF2-SWN schwannomas, highlighting the importance of considering these subgroups in future therapeutic research and clinical trial design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Neurosurgery, Beijing Key Laboratory of Drug Innovation for Neuro-Oncology, Beijing Neurosurgical Institute, Capital Medical University, 119 South 4th Ring West Road, Fengtai District, Beijing, 1…
- National Genomics Data Center, China National Center for Bioinformation & Beijing Institute of Genomics, Chinese Academy of Sciences, No. 1 Beichen West Road, Chaoyang District, Beijing, 100101, People's Republic of Chi…
- Department of Neurology, Yale School of Medicine, New Haven, CT, 06511, USA.
- Department of Neural Reconstruction, Beijing Key Laboratory of Central Nervous System Injury, Beijing Neurosurgical Institute, Capital Medical University, 119 South 4th Ring West Road, Fengtai District, Beijing, 100070,…
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119 South 4th Ring West Road, Fengtai District, Beijing, 100070, People's Republic of China.
- Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, People's Republic of China.
Förderung
- National Science and Technology Support Program of the 12th Five-Year Plan of China
- Beijing Platform Construction of Basic Research and Clinical Translation of Nervous System Injury (2020)
- Beijing Natural Science Foundation
Zitieren
APA
Zhao, F., Teng, X. F., Zhang, J., Li, S. W., Wang, L. M., Zhao, H. G., Zhang, S., Zhao, C., Li, P., Zhao, X. B., Song, S. H., & Liu, P. N. (2025). Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities. Acta Neuropathologica, 149(1). https://doi.org/10.1007/s00401-025-02883-6
Vancouver
Zhao F, Teng XF, Zhang J, Li SW, Wang LM, Zhao HG, et al. Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities. Acta Neuropathologica. 2025;149(1). doi:10.1007/s00401-025-02883-6
BibTeX
@article{Zhao2025,
author = {Zhao, Fu and Teng, Xu-Fei and Zhang, Jing and Li, Shi-Wei and Wang, Lei-Ming and Zhao, Han-Guang and Zhang, Shun and Zhao, Chi and Li, Peng and Zhao, Xiao-Bin and Song, Shu-Hui and Liu, Pi-Nan},
title = {Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities},
journal = {Acta Neuropathologica},
year = {2025},
volume = {149},
number = {1},
doi = {10.1007/s00401-025-02883-6}
}
EUVIMED